Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
64.47%
Operating Margin
61.72%
Net Margin
33.39%
Efficiency Metrics
Revenue per Expense Ratio
2.61
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
70.52%
Income Tax Rate
1.08%
EPS
6.5700000000
Balance Sheet Analysis
Current Ratio
0.76
Cash Ratio
0.76
Working Capital
$-163.59M
Debt to Equity
0.69
Debt to Assets
39.34%
Equity Ratio
56.98%
Cash Flow Analysis
Operating Cash Flow Ratio
56.29%
Free Cash Flow Ratio
49.19%
CapEx to Revenue
7.09%
Dividends Paid
$922.66M
Stock Buybacks
$1.91M
Total Shareholder Returns
$924.57M
Cash Position Change
-27.69%
Key Takeaways (2023 FY)
Increased dividend payments by 2.49%
Detailed Growth Metrics
Core Performance
Revenue
7.25%
Net Income
-18.29%
EPS
-19.19%
Operating Income
108.81%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
3.33%
Operating Cash Flow
9.71%
Free Cash Flow
9.26%
Balance Sheet Health
Assets
1.08%
Debt
-2.18%
Book Value per Share
3.46%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
2.49%
Shares Outstanding
1.20%
Long Term Trends
3Y Revenue/Share
19.83%
5Y Revenue/Share
19.11%
3Y Dividend/Share
3.57%
5Y Dividend/Share
12.10%